메뉴 건너뛰기




Volumn 1217, Issue 7, 2010, Pages 1063-1074

Lipase-mediated enantioselective kinetic resolution of racemic acidic drugs in non-standard organic solvents: Direct chiral liquid chromatography monitoring and accurate determination of the enantiomeric excesses

Author keywords

Chiralpak IB; Direct monitoring; Enantiomeric excess; Enantioselective HPLC; Kinetic resolution; Lipase; Racemic acidic drugs

Indexed keywords

ACIDIC DRUGS; CHIRALPAK IB; DIRECT MONITORING; ENANTIOMERIC EXCESS; ENANTIOSELECTIVE HPLC; KINETIC RESOLUTION;

EID: 74049101638     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2009.10.080     Document Type: Article
Times cited : (38)

References (42)
  • 2
    • 0026437190 scopus 로고
    • FDA's Policy statement for the development of new stereoisomeric drugs
    • FDA's Policy statement for the development of new stereoisomeric drugs, Chirality 4 (1992) 338.
    • (1992) Chirality , vol.4 , pp. 338


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.